LINC02189: A Long Intergenic Non-Protein-Coding RNA (G101928614)

Target Name: LINC02189

NCBI ID: G101928614

LINC02189

Other Name(s): long intergenic non-protein coding RNA 2189 | LOC101928614 variant X2 | Uncharacterized LOC101928614, transcript variant X2

LINC02189: A Long Intergenic Non-Protein-Coding RNA

LINC02189 is a long non-coding RNA (lncRNA) that has been identified in various studies as having important functional roles in various organisms, including humans. This RNA has been shown to play a key role in regulating gene expression and has been linked to a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, LINC02189 has potential as a drug target or biomarker.

Expression and Localization

LINC02189 is a long non-coding RNA that has been identified in various organisms, including humans. It is expressed in a variety of tissues and cells and has been shown to play a role in regulating gene expression.

One of the most significant findings related to LINC02189 is its localization to specific genomic regions. Studies have shown that LINC02189 is highly expressed in the brain and that it is enriched in certain brain regions, such as the prefrontal cortex and the cerebellum. Additionally, LINC02189 has been shown to be expressed in other tissues and cells, including muscle, heart, and blood cells.

Function and Interaction

The function of LINC02189 is not well understood, but it is known to play a role in regulating gene expression and has been linked to a number of diseases.

One of the most significant functions of LINC02189 is its role in regulating gene expression. Studies have shown that LINC02189 can interact with a variety of transcription factors and can modulate the activity of these factors. This suggests that LINC02189 plays a key role in regulating gene expression and that it may be a useful target for drugs that target gene expression.

In addition to its role in regulating gene expression, LINC02189 has also been shown to play a role in cellular signaling. Studies have shown that LINC02189 can interact with a variety of signaling proteins, including NF-kappa1, FGF1, and NF-kappa-B. This suggests that LINC02189 may be involved in cellular signaling and that it may be a useful target for drugs that target signaling pathways.

Disease Relevance

The link between LINC02189 and disease is an area of ongoing research. Studies have shown that LINC02189 is involved in a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

For example, studies have shown that LINC02189 is involved in the development and progression of cancer. Cancer cells have been shown to have increased levels of LINC02189 and to use this RNA to promote their growth and survival. Additionally, studies have shown that LINC02189 is involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its involvement in cancer and neurodegenerative diseases, LINC02189 has also been shown to be involved in the development and progression of developmental disorders. Studies have shown that LINC02189 is involved in the development and progression of a number of developmental disorders, including Down syndrome and Smith-Fetter syndrome.

Gene Expression

LINC02189 has been shown to play a role in regulating gene expression in a variety of organisms, including humans. Studies have shown that LINC02189 can interact with a variety of transcription factors and can modulate the activity of these factors. This suggests that LINC02189 plays a key role in regulating gene expression and that it may be a useful target for drugs that target gene expression.

Expression Analysis

To further study the function of LINC02189, researchers have used a variety of techniques to analyze its expression in different organisms

Protein Name: Long Intergenic Non-protein Coding RNA 2189

The "LINC02189 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02189 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets